- Country: Ecuador
- Summary: "Acquisition of Group J4 Medicines (Anti-Infective for Systemic Use (Parenteral Liquids/Solids)) for the General Hospital Del Norte De Guayaquil Los Ceibos"
- ECT Ref No: 112384813
- Deadline: 03 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: USD 541366.85
- Notice Type: Tender
- Document Ref. No.: SIE-HGNGC-2024-118
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Process Object: "ACQUISITION OF DRUGS GROUP J4 (ANTINFECTIVE FOR SYSTEMIC USE (PARENTERAL LIQUIDS/SOLIDS)) FOR THE GENERAL DEL NORTE HOSPITAL OF GUAYAQUIL LOS CEIBOS"
Purchase Type: Good
Description: "ACQUISITION OF DRUGS GROUP J4 (ANTINFECTIVE FOR USE SYSTEMIC - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN"Acquisition of Group J4 Medicines (Anti-Infective for Systemic Use (Parenteral Liquids/Solids)) for the General Hospital Del Norte De Guayaquil Los Ceibos" - Ecuador Tender
The GENERAL HOSPITAL OF THE NORTH OF GUAYAQUIL LOS CEIBOS, a Government sector organization in Ecuador, has announced a new tender for "Acquisition of Group J4 Medicines (Anti-Infective for Systemic Use (Parenteral Liquids/Solids)) for the General Hospital Del Norte De Guayaquil Los Ceibos". This tender is published on EcuadorTenders under ECT Ref No: 112384813 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-03.
The estimated tender value is USD 541366.85, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
